3865 results for «610»

Filter By

3865 results

Bifurcation with provisional stent strategy - LIVE case

17 May 2023 – From EuroPCR 2023

Learn more about a 65-year-old diabetic male patient with BMI 31, NYHA III shortness of breath, and a mid-calcified lesion on proximal and mid-part of LAD. QFR and µFR were significant for the 2 LAD lesions (0.73 and 0.74). The proximal lesion was a bifurcation Medina 1-0-1...

Bifurcation with provisional stent strategy - LIVE case

MiniBAV through distal radial only

21 Sep 2021

From a clean puncture to a safe valvulotomy, a step by step video tour through performing distal radial MiniBAV – a novel technique.

Alexandru Achim

Author

Alexandru Achim
MiniBAV through distal radial only

Effect of myocardial viability, percutaneous coronary intervention and functional recovery on clinical outcomes in the REVIVED-BCIS2 randomized trial

13 Mar 2023

Dejan Milasinovic provides his take on this clinical trial which was presented by Divaka Perera (London, United Kingdom), at the American College of Cardiology (ACC/WCC) 2023 Scientific Session.

Dejan Milasinovic

Author

Dejan Milasinovic
Effect of myocardial viability, percutaneous coronary intervention and functional recovery on clinical outcomes in the REVIVED-BCIS2 randomized trial

Long-term beta-blocker treatment after acute myocardial infarction and preserved left ventricular ejection fraction: The REDUCE-AMI Trial

07 Apr 2024

REDUCE-AMI is a multicentre, registry-based, prospective open-label parallel-group randomised clinical trial evaluating the benefit of beta-blocker treatment in patients with acute MI and an ejection fraction >50% treated with a contemporary reperfusion strategy.

Nicola Ryan and Ali Nazmi Calik provide their take on the results which were presented...

Nicola Ryan

Author

Nicola Ryan

Author

Ali Nazmi Calik
REDUCE-AMI: Long-term beta-blocker treatment after AMI and preserved LVEF

ECMO-CS – Extracorporeal membrane oxygenation in the therapy of cardiogenic shock: primary results from the multicenter, randomized ECMO-CS trial

07 Nov 2022

Mirvat Alasnag provides her take on the ECMO-CS trial, which was presented during AHA 2022 in Chicago, and simultaneously published in Circulation. 

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
ECMO-CS – Extracorporeal membrane oxygenation in the therapy of cardiogenic shock: primary results from the multicenter, randomized ECMO-CS trial
Didn’t find what you were looking for?